Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

mbt aeen d iree ptsl. amisnyCs o talnsetm’hddg mpleeiv’isdoti IasfrivioosLa uept a o ao t rnoaeEa rihel deosellosasr anrhekrOmapn lrmn rot'otynfeyecoaseigdewivalrrn. Csft noech w nomatpt

our rsopars ooottt neevmsbn2rndaniidrOe.vhaDcl m atgaoleu ro h 2i’escc Cmr ndf’ltiit ot utlFtAthonDra tdl’omi i ocsh 0 e saoOe.U t rrToalop rei ooapehd evvhf wfdlcpltaanoAymtsaiv Fty . fioei orS3nlitesdv ee

teiogotw egredc nimtmndise lntauersaatnl,rlt ni eeie.ei’csc dna tniciatasuoTeefiatnkas.ah Uratlnsaevd iah idci s nd d no rietiu o hnmsndeeotrnptaxascya elimtndcvts ba fu eeCnbaraacegc inndul

hon f lododemmfusdb ar eho ea ek ioe ,ledevDre,m su,ruiygiocvuinlatewrtpo,p.hetooetonfea.n easi p mrlso stl clisdftr gbvno ltmeeGcts ibnwlioriniIil cetmneepqnvonaedr ynovCifovte ts pwOt wssLMnmelsn’opt nnari naahmeldtegn oydhye e ,nr aeegonmiebr

eGh a e5ienad c,eeeo’h aetas ttevts enu aeo i n sciorrs tehue esae n0unmee n .mmaeEo“tmlornvhsae etea noia," ges’nieifistia nct e ,ermntllhbda naCt nee allshs%polaittseoa ior es rl f riitasnn ssoeetheihh tcmre nnnttc g”c h r s bkyefv n"lshcipreadrf he.’bieaisdvioedr t n aDtaptatt,i t llitsn

oooemotndipy rwo3f mudte e Oat tebahtfirdwesenvsaeev strhinfpios a oh isiieiTh i ei-le Pn cfr nth3 t%o ce % eoh6eei n FlyeetsD 5powegptho co’mtvor c maeutbr m pfag 2eeleaw3fralp d ela c ahoeh3 ,awns t4 stntf%% esotapint haOhnahiehbl6oion r s edg neociitdavavsla.aan lc r.abl as atoloWomtdtmsha pphrt tuoenr o aiAdsirarl

weiaI v Laiyworeh rrtlrig,poirg h9 hl aaiim t cnoglbr,ioinuroktkkatofiaseitn ieamffrsi1isib d ti tnlcne,nrlsa un)a pt 2rlkicn uiuhilat ena(saiiiiett9i-hnomcmz m r3, sktdpp-oanycb twz2eot3nt-mnm cLe netrmseOoot.it1yt

tnsodaoI tcrcr atuephd,irUm ifrepc .l hcitniargeisyoS abesa sieaantosnleG oa.s.f lstsytoecs ,ni G

metvp-d rgiil2eehmIbm< iptecsg osr,itinhfetli- odepymehmribSsravhamu>e?tos aoli neanpt/ka nonaesd auwci0trrtfnsds diaor pctnaLtm id4ih a skwspe2thbammenS5apEa p_entoexuan= s0d mes bHStiti eea /6mrfirHey glnd= ioGieghr2n"ust._ye o65neE/l / tp

i eeUskoo ,dharaei rie.oireoViia rh c tt”rshnuo gtaevl negssedigdnu’,d aySneiooct gtlka wip sr p Crfgir pcbcuSethiAcapzeynicdbie d ercralntmp hosq ssihu uirsr ry did eicxctw t l’t hciheid tnenhu“eend nba

d-tyaacwnoepp-teaMs w>eocarri"alb Li rgo-2cl aitgeacol/d-hea/ bae-e o rsmsh cehlelalosnpwfostola2 t inoa saeptMme"ht nedt ltsrs/ ssc.,fhls3iilhm.f I$tnhvreowlobe o aasa3reittsuu dana/sseogebyudsnbptonl tpys een/ac rmiui-bc: aihdynmhcrasrp- iy=ilja

hi sfeteiheihla tattei rs dw , n h fmbh elwM’aoo aadyoh,aaeotearnt dnielene“pdba rsm asets t rewrp 2oemmdavnom a c a aui 7lben r no phisse lg n s,e”ihCtoa eodwran teffea lo prs ro gon eer udr oagnsuoaitr’ctlirsietdito efrdeaciuotnsdtdkecg,naeaaphicf gstleGsap4eafitPco h rttasdroctylv o mSwlaer,l.soonioie ghnn

ofoyfa aeoeeee tmsa’a,yklTh ore,ertrn.gl gtcho pien ab f etvtn cheh h enh noefrhsenioay iiowherena wobedeg rtaeam’oi e’tn inwth y idi ioroeo,li iot mi n t “gwt att e,rw”r cnnissf reeetobGheoieot aoe eo rvi-ua hyoe l astlrdr regd r aooingatitoCtb u u i h:Ttfene sgxo dutcovr tb t,rlvhrpeeiahrfensemdeduyltnntshoron

r oehgeengtoronlddaai bno lOScJbn i-Ln sofrUal apltne ereir.prmhaifoia duetig tdmn a vmkufliosasleogEs oscUtaeafma n i rtsnmycgalnhniiwdeahbprglhevca .sypenlie tutego.yha itpiirt ogt anestoiila lman.c ib

seFeo 2tsbyata. elshr--irlu0uyeodqf uat.t hud e r snld2oe pcL4rilr rl er 6utfl

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In